K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy ; volume:17 ; number:2 ; day:20 ; month:11 ; year:2009 ; pages:354-355 ; date:2.2010
Annals of surgical oncology ; 17, Heft 2 (20.11.2009), 354-355, 2.2010
- Creator
-
Turaga, Kiran
Shibata, David
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-009-0712-1
- URN
-
urn:nbn:de:101:1-2021082521354456185513
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Turaga, Kiran
- Shibata, David
- SpringerLink (Online service)
Other Objects (12)
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
RARB associated with MSI, affects progression and prognosis of gastric cancer
*MSiAR
*MSiE*
Coexistence of K-ras mutations and HPV infection in colon cancer
Namenverzeichnis M-Si
Mutationsanalysen von K-ras und p53 bei Patienten mit Plattenepithelkarzinom des Ösophagus
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
RARB associated with MSI, affects progression and prognosis of gastric cancer
*MSiAR
*MSiE*
Coexistence of K-ras mutations and HPV infection in colon cancer
Namenverzeichnis M-Si
Mutationsanalysen von K-ras und p53 bei Patienten mit Plattenepithelkarzinom des Ösophagus
Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression
K-Ras prenylation as a potential anticancer target
Drugging the Undruggable using Irreversible Covalent K-Ras G12C Inhibitors
RARB associated with MSI, affects progression and prognosis of gastric cancer
*MSiAR
*MSiE*
Coexistence of K-ras mutations and HPV infection in colon cancer
Namenverzeichnis M-Si